Canada markets closed

Protagonist Therapeutics, Inc. (PGF.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
15.200.00 (0.00%)
At close: 08:29PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-130,106
-78,955
-127,393
-125,551
-66,150
Depreciation & amortization
3,348
3,312
3,369
2,775
2,723
Deferred income taxes
-
-
0
0
1,438
Stock based compensation
23,714
29,293
24,202
16,395
7,899
Change in working capital
-1,271
-19,511
-7,766
-3,314
-19,016
Accounts Payable
4,016
-2,868
2,045
-1,390
309
Other working capital
-104,362
-70,845
-108,932
-108,966
-72,955
Other non-cash items
194
194
-
-
159
Net cash provided by operating activites
-103,441
-70,236
-108,137
-107,865
-72,484
Cash flows from investing activities
Investments in property, plant and equipment
-921
-609
-795
-1,101
-471
Purchases of investments
-164,966
-191,045
-214,874
-286,589
-280,027
Sales/Maturities of investments
281,287
152,396
307,137
271,830
189,533
Net cash used for investing activites
115,400
-39,258
91,468
-15,860
-90,965
Cash flows from financing activities
Debt repayment
-
-
0
0
-10,524
Common stock issued
14,387
132,100
14,553
123,829
255,365
Other financing activites
-163
-769
-163
-189
-14
Net cash used privided by (used for) financing activities
20,458
170,477
18,838
129,923
247,626
Net change in cash
32,274
60,983
2,079
6,072
84,352
Cash at beginning of period
120,767
125,969
123,890
117,818
33,466
Cash at end of period
153,184
186,952
125,969
123,890
117,818
Free Cash Flow
Operating Cash Flow
-103,441
-70,236
-108,137
-107,865
-72,484
Capital Expenditure
-921
-609
-795
-1,101
-471
Free Cash Flow
-104,362
-70,845
-108,932
-108,966
-72,955